Catalyst Awards support researchers with $500,000 over two years in developing innovative approaches to uncover new insights into cognitive health and the prevention or reversal of neurodegenerative disease.
We also offer Catalyst Momentum Awards, which are an opportunity for current awardees to extend their project funding for an additional two years. These awards aim to provide continued momentum to existing projects and further advance the impactful work begun under the Catalyst Award program.
“After decades of darkness and only a few clues, the discovery of clear genetic risk factors and biomarkers [of neurodegeneration] now allows us to formulate compelling hypotheses. Thanks to this Catalyst Award from the Knight Initiative, our team is now able to shed light on key mechanisms of how the brain fends off ongoing pressures to decline.”
“After decades of darkness and only a few clues, the discovery of clear genetic risk factors and biomarkers [of neurodegeneration] now allows us to formulate compelling hypotheses. Thanks to this Catalyst Award from the Knight Initiative, our team is now able to shed light on key mechanisms of how the brain fends off ongoing pressures to decline.”
Catalyst Momentum Award projects
Understand the regulatory dynamics of “resilience networks” during development, healthy aging and disease models (renewed)
Preserving Motor Engrams in Parkinson's Disease: Neural Circuit and Transcriptomic Studies and Strategies for Resilient Motor Control (renewed)
Predicting and promoting resilient brain aging trajectories (renewed)
Mapping Cell-Type-Specific Lysosomal Content
Catalyst Award projects
Harnessing ketone metabolites for brain health and brain resilience
Identifying the intrinsic biological factors of APOE risk and resilience across relevant iPSC-derived brain cell types
Catalyst Award Applications are currently closed
See the resources below for past application details.